Morgan Stanley Starts CG Oncology (CGON ) at Overweight, 'Disrupting the Bladder Cancer Treatment Landscape'
Tweet Send to a Friend
(Updated - February 20, 2024 3:35 AM EST)
Morgan Stanley analyst Jeffrey Hung initiates coverage on CG Oncology (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Jeffrey Hung initiates coverage on CG Oncology (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
